Drug pipeline
Full profile accessExplore the programs pursuing this target and their development progress.
- Drug candidates
- Developers
- Development stage
Target intelligence / Profile preview
Integrin alpha-3 is a transmembrane receptor protein encoded by the ITGA3 gene, functioning as the alpha subunit of the α3β1 integrin heterodimer. This receptor binds to extracellular matrix proteins, including laminin, fibronectin, and collagen, and mediates adhesion, migration, and signal transduction in epithelial, neural, and other cell types. Integrin alpha-3 plays critical roles in embryonic development, especially neural migration and corticogenesis, and is implicated in processes such as cell invasion (cancer metastasis), tissue integrity, and immune cell function. Dysregulation or mutation of ITGA3 is associated with diseases such as cancer, nephrotic syndrome, and autoimmune inflammation
Drugs or antibodies targeting integrin alpha-3 typically act by inhibiting binding of the integrin to its extracellular matrix ligands (e.g., laminins, fibronectin, collagen), thereby blocking cell adhesion, migration, and invasion processes relevant in cancer and inflammation
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Explore the programs pursuing this target and their development progress.
Follow the clinical studies evaluating therapies directed at this target.
Compare approaches across drug candidates, modalities, and indications.
Investigate the research and source evidence behind target biology and development.
Explore patent activity around therapies and technologies addressing this target.
Connect target biology, drug development, and emerging evidence in your research.
See how Gosset can support your research on Integrin alpha-3 (ITGA3).